Alqahtani Amani S, Bondagji Daniah M, Alshehari Abdullah A, Basyouni Mada H, Alhawassi Tariq M, BinDhim Nasser F, Rashid Harunor
Amani S Alqahtani, Daniah M Bondagji, School of Public Health, the University of Sydney, Sydney, New South Wales 2006, Australia.
World J Clin Cases. 2017 Jun 16;5(6):212-221. doi: 10.12998/wjcc.v5.i6.212.
To study the uptake, barriers and motivators of influenza, pneumococcal, meningococcal and pertussis vaccines among members of public in Arabian Gulf countries.
A cross-sectional survey among the Gulf Cooperation Council (GCC) countries' residents. Data collected electronically through a smartphone app. The survey variables aimed to investigate the respondents' awareness about vaccines against influenza, pneumococcal, meningococcal and pertussis infections. Collected data concerning the respondents' socio-demographic characteristics, their perception toward vaccine uptake and the factors that motivate or demotivate them from taking influenza vaccine. The data were analysed statistically using the SPSS v.23.0. Differences in the characteristics of users from different countries were quantified through bivariate analysis. Other important variables and controlling factors were studied using logistic regression.
A total of 1812 respondents participated in the study. Their mean age was 27 years, 82% were male and 24% had ≥ 1 chronic diseases. The overall uptake of influenza vaccine was 17% (21% among "at risk" people) and ranged from 15% in Saudi Arabia to 24% in Qatar. Doctor's advice (23%) and a perception of having low body immunity (21%) were the main cited reasons for being vaccinated, whereas unawareness about the vaccine (43%) was the main barrier. The overall uptake of pneumococcal vaccine in the preceding three years was 22% (25% among "at risk" individuals) and ranged from 0% in Bahrain to 79% in Kuwait. The overall uptake of pertussis vaccine was 16% (31% among "vulnerable" people), and ranged from 7% in Saudi Arabia to 75% in Oman. The overall uptake of meningococcal vaccine was 20% (29% among the "at risk" people) and ranged from 3% in Oman to 50% in Bahrain.
The vaccination uptake across GCC countries is suboptimal and varies widely across the countries. Further research is needed to unearth the reasons and formulate action plan.
研究阿拉伯海湾国家公众对流感、肺炎球菌、脑膜炎球菌和百日咳疫苗的接种情况、障碍及动机。
对海湾合作委员会（GCC）国家居民进行横断面调查。通过智能手机应用程序以电子方式收集数据。调查变量旨在调查受访者对预防流感、肺炎球菌、脑膜炎球菌和百日咳感染疫苗的认知。收集有关受访者社会人口特征、他们对疫苗接种的看法以及促使或阻碍他们接种流感疫苗的因素的数据。使用SPSS v.23.0对数据进行统计分析。通过双变量分析量化不同国家使用者特征的差异。使用逻辑回归研究其他重要变量和控制因素。
共有1812名受访者参与了该研究。他们的平均年龄为27岁，82%为男性，24%患有≥1种慢性病。流感疫苗的总体接种率为17%（“高危”人群中为21%），范围从沙特阿拉伯的15%到卡塔尔的24%。医生建议（23%）和认为自身免疫力低（21%）是接种疫苗的主要原因，而对疫苗不了解（43%）是主要障碍。前三年肺炎球菌疫苗的总体接种率为22%（“高危”个体中为25%），范围从巴林的0%到科威特的79%。百日咳疫苗的总体接种率为16%（“易感”人群中为31%），范围从沙特阿拉伯的7%到阿曼的75%。脑膜炎球菌疫苗的总体接种率为20%（“高危”人群中为29%），范围从阿曼的3%到巴林的50%。
海湾合作委员会国家的疫苗接种率未达最佳水平，且各国之间差异很大。需要进一步研究以找出原因并制定行动计划。
